Applications Published 27 March 2002

Pharmaceutical compsn for nasally administering water-soluble active substances
Kloecker, Norbert 1189596*

Oil-core compsns for the sustained release of hydrophobic drugs
SkyePharma 1189597*

A method for the improvement of transport across adaptable semi-permeable barriers
Idea 1189598*

Pharmaceutical materials and methods for their preparation and use
Eli Lilly 1189599*

GRF-containing lyophilised pharmaceutical compsns
Applied Research Systems 1189600*

Delayed total release two pulse gastrointestinal drug delivery system
Dexcel Pharma Technologies 1189601*

Morphine sulphate microgranules, method for preparing same and compsns containing same
Laboratoires des Produits Ethiques Ethypharm 1189602*

Treatment of immune diseases like HIV disease and neoplastic disorders
Immugen Pharmaceuticals 1189603*

Zinc ionophores as anti-apoptopic agents
Zinc Therapeutics Canada 1189604*

High molecular weight primary aliphatic alcohols obtained from beeswax and pharmaceutical use thereof
Cholesterol Control Laboratories 1189605*

Novel iron chelators and pharmaceutical compsns comprising iron chelators for the treatment of neurodegenerative disorders
Yeda Research & Development 1189606*

Anti-tumour activity of vitamin E, cholesterol, taxol and betulinic acid derivatives
Washington State University Research Foundation 1189607*

Levodopa/carbidopa/entacapone pharmaceutical preparation
Orion Corp 1189608*

CXCR-4 receptor anagonists - thrombopoietin mimetics
SmithKline Beecham 1189609*

Method and markers for prognosticating efficacy of anticancer agents
Bristol-Myers Squibb 1189610*

Cancer therapy
Cancer Research Ventures 1189611*

VLA-4 inhibitor compounds
Daiichi Pharmaceutical; Pharmacopeia 1189612*

Method for treatment of neurological or neuropsychiatric disorders
Clarencew 1189613*

Solid preparations containing paroxetine
Knoll 1189614*

Endoparasiticidal synergistic combination containing cyclic depsipeptides and piperazines
Bayer 1189615*

S-hydroxynefazodone
Sepracor 1189616*

Novel pharmaceutical combination with analgesic action containing paracetamol and buspirone
Laboratoires UPSA 1189617*

Thrombin inhibitors
Merck 1189618*

Administration of non-oral androgenic steroids to women
Watson Pharmaceuticals 1189619*

Formulation comprising testosterone undecanoate and castor oil
Akzo Nobel 1189620*

Unfermented gel fraction from psyllium seed husks
Wisconsin Alumni Research Foundation 1189621*

Anionic polymers as toxin binders and antibacterial agents
Geltex Pharmaceuticals 1189622*

Method and compsn for inhibiting cardiovascular cell proliferation
The Board of Trustees of the Leland Stanford Junior University 1189623*

HLA binding peptides and their uses
Epimmune 1189624*

Pharmaceutical preparation containing modifications of surfactant protein B (SP-B) and surfactant protein C (SP-C)
Byk Gulden Lomberg Chemische Fabrik 1189625*

Method for preventing tumoral growth
BASF 1189626*

Compsns containing soluble forms of HLA-G for treating inflammatory skin pathologies
Commisariat a l'Energie Atomique 1189627*

Combination of tumour necrosis factor (TNF) antagonists and COX-2 inhibitors for the treatment of inflammation
Pharmacia 1189628*

Methods and reagents for treating glucose metabolic disorders
Curis 1189629*

A method of prophylaxis and treatment and agents useful for same
University of Sydney 1189630*

Neurodegenerative disorder related gene
The University Court of the University of Glasgow 1189631*

Pneumococcal surface protein combination vaccine
UAB Research Foundation; Aventis Pasteur; Centers for Disease Control & Prevention 1189632*

Method for treating chronic HBV infection
Chiron Corp 1189633*

Treating prostate cancer with anti-ERBB2 antibodies
Genentech; Sloan-Kettering Institute for Cancer Research 1189634*

Autologous adoptive immunotherapy with primed antigen-specific T cells or B cells
University of Vermont and State Agricultural College 1189635*

A method of treatment of human immunodeficiency diseases
Khatchatrian, Robert; Katchatrian, Ashot 1189636*

Compsns for improving bioavailability of orally administered drugs
Cancer Research Ventures 1189637*

Pharmaceutical compsn containing sibutramine and a lipase inhibitor
Knoll 1189638*

Filler binder for tablets
Cooeperatie Cosun 1189639*

Pharmaceutical complex
Pfizer 1189640*

Humanised anti-ERBB2 antibodies and treatment with anti-ERBB2 antibodies
Genentech 1189641*

Biologically active material based on an insolubilised dextran derivative and a growth factor
Biodex 1189644*

Non-covalent bioconjugates useful for diagnosis and therapy
Mallinckrodt 1189645*

Implantable drug delivery system
Elver, Sten-Olof; Skansen, Jan 1189647*

Combination for treating weight gain associated with antipsychotic use comprising an atypical antipsychotic and an H2 agonist
Eli Lilly 1189662*

Synergy between low molecular weight heparin and platelet aggregation inhibitors, for preventing and treating thromboembolic disorders
Du Pont Pharmaceuticals 1189663*

Excitatory amino acid receptor modulators
Lilly 1189873*

Mono and multifunctional alkoxyamines for the preparation of functionalised macromers
Ciba Specialty Chemicals 1189875*

Inhibitors of Factor XA
Cor Therapeutics 1189879*

Propanoic acid derivatives that inhibit the binding of integrins to their receptors
Texas Biotechnology Corp 1189881*

Biphenyl butyric acid derivative as a matrix metalloproteinase inhibitor
Samsung Electrical 1189882*

Substituted pyrrolidine as cell adhesion inhibitors
Aventis Pharma 1189883*

Ethanesulphonyl-piperidine derivatives
F Hoffmann-La Roche 1189886*

Process for preparing 10,11-methanobenzosuberane derivatives
Eli Lilly 1189887*

Heterosubstituted pyridine derivatives as PDE4 inhibitors
Merck Frosst Canada 1189888*

Compsns and methods for inhibiting cell death
Elan Pharma International 1189889*

Dihydrobenzodiazepins and their use for treating dyslipidemia
Merck 1189890*

Triazole compounds and combinatorial libraries thereof
LION Bioscience 1189891*

Melamine derivatives as potent anticancer agents
Parker Hughes Institute 1189892*

Substituted 2-aryl-1,2,4-triazine-3,5-di(thi)one
Bayer 1189893*

Thiazolidine carboxylic acid derivatives and their use in the treatment of cancer
F Hoffmann-La Roche 1189894*

Thiazole and oxazole derivatives and their pharmaceutical use
Glaxo Group 1189895*

Isoflavone metabolites
GJ Consultants 1189897*

Heterocyclic aminopyrrolidine derivatives as melatonergic agents
Bristol-Myers Squibb 1189900*

Oxazaheterocycles as protease inhibitors
3-Dimensional Pharmaceuticals 1189901*